Company
DYN · CIK 0001818794
Sale of 5,658 shares at $18.88 per share.
Reporting Person Cox John · Officer Title CEO & President · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0001498428-26-000005 · filed 2026-09-08 · View filing →
Sale of 1,290 shares at $18.88 per share.
Reporting Person Kerr Douglas · Officer Title Chief Medical Officer · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0001814189-26-000005 · filed 2026-09-08 · View filing →
Sale of 185 shares at $18.88 per share.
Reporting Person Friedl-Naderer Johanna · Officer Title Chief Commercial Officer · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0001915598-26-000005 · filed 2026-09-08 · View filing →
Sale of 3,745 shares at $24.35 per share.
Reporting Person Kerr Douglas · Officer Title Chief Medical Officer · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0001814189-26-000005 · filed 2026-09-08 · View filing →
Sale of 900 shares at $24.35 per share.
Reporting Person Friedl-Naderer Johanna · Officer Title Chief Commercial Officer · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 8, 2026
Source: SEC Form 4 · 0001915598-26-000005 · filed 2026-09-08 · View filing →
Sale of 1,359,674 shares at $25 per share.
Reporting Person Rhodes Jason P · Transaction Code S
Traded Aug 14, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001577014-26-000016 · filed 2026-08-17 · View filing →
Sale of 478,377 shares at $25 per share.
Reporting Person Rhodes Jason P · Transaction Code S
Traded Aug 14, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001577014-26-000016 · filed 2026-08-17 · View filing →
Sale of 322,465 shares at $25 per share.
Reporting Person Rhodes Jason P · Transaction Code S
Traded Aug 14, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001577014-26-000016 · filed 2026-08-17 · View filing →
Sale of 4,986 shares at $26.28 per share.
Reporting Person Cox John · Officer Title CEO & President · Transaction Code S
Traded Aug 13, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001498428-26-000004 · filed 2026-08-17 · View filing →
Sale of 268,354 shares at $26.20 per share.
Reporting Person Rhodes Jason P · Transaction Code S
Traded Aug 13, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001577014-26-000016 · filed 2026-08-17 · View filing →
Sale of 94,415 shares at $26.20 per share.
Reporting Person Rhodes Jason P · Transaction Code S
Traded Aug 13, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001577014-26-000016 · filed 2026-08-17 · View filing →
Sale of 63,643 shares at $26.20 per share.
Reporting Person Rhodes Jason P · Transaction Code S
Traded Aug 13, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001577014-26-000016 · filed 2026-08-17 · View filing →
Sale of 1,797 shares at $26.28 per share.
Reporting Person Lucera Erick · Officer Title Chief Financial Officer · Transaction Code S
Traded Aug 13, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001697616-26-000002 · filed 2026-08-17 · View filing →
Sale of 1,556 shares at $26.28 per share.
Reporting Person Kerr Douglas · Officer Title Chief Medical Officer · Transaction Code S
Traded Aug 13, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001814189-26-000004 · filed 2026-08-17 · View filing →
Sale of 226 shares at $26.28 per share.
Reporting Person Friedl-Naderer Johanna · Officer Title Chief Commercial Officer · Transaction Code S
Traded Aug 13, 2026 · Disclosed Aug 17, 2026
Source: SEC Form 4 · 0001915598-26-000004 · filed 2026-08-17 · View filing →